Product image of Mercaptopurina Accord (Mercaptopurine Monohydrate) supplied by GNH India

Mercaptopurina Accord

Active Ingredient:
Mercaptopurine Monohydrate
Origin:
EU

Mercaptopurina Accord (Mercaptopurine Monohydrate)

Mercaptopurine, the active ingredient in Mercaptopurina Accord, is an antimetabolite (purine analog) presented as an oral tablet for oral use. It is employed in the treatment of acute lymphoblastic leukemia and as an immunosuppressant in inflammatory bowel disease, targeting rapidly dividing cells.

GNH India supplies Mercaptopurina Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable bulk and packaged supplies to meet clinical demand.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mercaptopurine is used in hematologic malignancies and inflammatory bowel disorders, acting as a purine synthesis inhibitor.

  • Acute lymphoblastic leukemia (ALL): helps achieve remission by inhibiting proliferation of lymphoblasts.
  • Crohn's disease: reduces intestinal inflammation and supports maintenance of remission.
  • Ulcerative colitis: controls disease activity and promotes mucosal healing.

How It Works

  • Mercaptopurine is converted intracellularly to thio‑inosine monophosphate, which blocks de novo purine synthesis and incorporates into DNA and RNA. This interferes with nucleic acid formation, leading to cytotoxicity in rapidly dividing cells such as malignant lymphoblasts and activated immune cells, thereby exerting antineoplastic and immunosuppressive effects.

Side Effects

Mercaptopurine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Vomiting: occasional episodes after dosing.
  • Loss of appetite: reduced desire to eat.
  • Mild leukopenia: slight decrease in white blood cells.
  • Rash: skin irritation or mild eruption.
  • Fatigue: general tiredness.

Serious or Rare Side Effects

  • Severe bone marrow suppression: profound pancytopenia.
  • Hepatotoxicity: elevated liver enzymes or liver injury.
  • Pancreatitis: inflammation of the pancreas.
  • Severe infections: opportunistic bacterial or fungal infections.
  • Hypersensitivity reactions: anaphylaxis or severe skin reactions.
  • Secondary malignancies: rare development of other cancers.

Precautions & Warnings

When prescribing Mercaptopurine, clinicians should observe several precautionary measures to minimize risk.

  • Monitor blood counts: perform regular CBC to detect myelosuppression.
  • Assess liver function: check hepatic enzymes before and during therapy.
  • Adjust dose in renal/hepatic impairment: reduce dosage based on organ function.
  • Avoid use in pregnancy unless benefits outweigh risks: discuss with obstetric specialist.
  • Counsel patients on infection signs: advise immediate medical attention for fever or sore throat.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Mercaptopurine interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid)

  • Allopurinol: markedly increases mercaptopurine toxicity.
  • Azathioprine: additive myelosuppressive effect.
  • Warfarin: enhanced anticoagulant activity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may increase gastrointestinal irritation.
  • ACE inhibitors: potential renal function impact.
  • Live vaccines: risk of infection due to immunosuppression.

Frequently Asked Questions

Mercaptopurina Accord contains mercaptopurine, an antimetabolite used primarily to treat acute lymphoblastic leukemia and to manage inflammatory bowel diseases such as Crohn's disease and ulcerative colitis by suppressing abnormal immune activity.

Mercaptopurine is metabolized inside cells to thio‑inosine monophosphate, which blocks purine synthesis and becomes incorporated into DNA and RNA. This disrupts nucleic acid formation, leading to cell death in rapidly dividing malignant or immune cells.

The exact dose is individualized by the prescribing clinician based on factors such as the patient’s age, body surface area, disease severity, and laboratory values, especially blood counts and liver function. No standard dose is provided here.

Data on mercaptopurine use in pregnancy and lactation are limited. It is generally avoided unless the potential benefit justifies the risk, and breastfeeding is discouraged because the drug can be excreted in milk. Consultation with a specialist is essential.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both mercaptopurine and azathioprine are purine analogues that suppress the immune system, but mercaptopurine is the active metabolite of azathioprine. Mercaptopurine often provides more predictable pharmacokinetics, while azathioprine requires conversion and may have variable activation.

Store the product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture and direct sunlight to maintain stability throughout its shelf life.

Mercaptopurina Accord is taken orally, usually as a tablet, with a glass of water. It may be taken with or without food, but patients should follow the specific instructions given by their healthcare provider.

The most critical risks include severe bone‑marrow suppression leading to pancytopenia, hepatotoxicity, pancreatitis, life‑threatening infections, and rare hypersensitivity reactions. Prompt medical evaluation is required if symptoms such as fever, jaundice, severe abdominal pain or rash develop.

Patients with known hypersensitivity to mercaptopurine, severe liver disease, uncontrolled infections, or those who are pregnant without a clear therapeutic justification should avoid the drug. Additionally, individuals taking interacting medications listed under major interactions should not use it without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.